<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 16-year-old girl treated with <z:chebi fb="0" ids="6067">isotretinoin</z:chebi> at a dosage of 0.7 mg per kg each day experienced severe <z:hpo ids='HP_0002315'>headaches</z:hpo> and impaired night vision two months after the start of therapy </plain></SENT>
<SENT sid="1" pm="."><plain>Bilateral <z:hpo ids='HP_0001085'>papilledema</z:hpo> and narrowing of the lateral ventricles of the brain were found </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">Pseudotumor cerebri</z:e> and impaired night vision abated when <z:chebi fb="0" ids="6067">isotretinoin</z:chebi> was discontinued and systemic <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> (<z:chebi fb="0" ids="41879">dexamethasone</z:chebi>) were administered </plain></SENT>
</text></document>